Erythrocyte function modifying substance

Details Erythrocyte function modifying substance Erythrocyte function modifying substance

A - Human Necessities

61

K

A61K 45/00 (2006.01) A61K 31/195 (2006.01) A61K 33/00 (2006.01) A61P 9/00 (2006.01) A61P 9/08 (2006.01) A61P 9/10 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2553931

A promoter of ATP release from red blood cells, comprising a substance capable of stabilizing the structure of hemoglobin in red blood cells in its T-state; and a method of releasing ATP from red blood cells with the use of the promoter. There are further provided an inhibitor of ATP release from red blood cells, comprising a substance capable of stabilizing the structure of hemoglobin in red blood cells in its R-state; and a method of inhibiting ATP release from red blood cells with the use of the inhibitor.

Agent promoteur de libération d~adénosine triphosphate par les globules rouges, comprenant une substance capable de stabiliser la structure de l~hémoglobine dans les globules rouges dans leur état T ; méthode de libération de l~adénosine triphosphate par les globules rouges avec utilisation d~un agent promoteur. Agent inhibiteur de libération d~adénosine triphosphate par les globules rouges, comprenant une substance capable de stabiliser la structure de l~hémoglobine dans les globules rouges dans leur état T ; méthode d'inhibition de la libération d'adénosine triphosphate par les globules rouges grâce à un inhibiteur.

Affiliated with

Also associated with

Rating

Erythrocyte function modifying substance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythrocyte function modifying substance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythrocyte function modifying substance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1448970